On-Demand webinar
Summary:
Hepatitis is an inflammation of the liver that can cause a range of health problems and can be fatal. There are five main strains of the hepatitis virus, referred to as types A, B, C, D and E. While they all cause liver disease, they differ in important ways including modes of transmission, severity of the illness, geographical distribution, and prevention methods. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis, cancer, and viral hepatitis-related deaths. This presentation is an overview of viral hepatitis A, B, and C, including the clinical aspects and modes of transmission. There is particular emphasis on the serologic diagnosis of the various types of hepatitis and the interrelationship of the various diagnostic markers.
Speaking on these findings, Dr. Jim Aguanno, PhD, senior clinical consultant at Siemens Healthineers, will help you:
- Discuss various aspects of hepatitis including the causes, scope of the disease, clinical features, mode of transmission and serologic diagnosis.
- Discuss the relationship of the various hepatitis serologic markers in Hepatitis A, Hepatitis B, and Hepatitis C
- Discuss effect hepatitis mutants on hepatitis B assays
Speaker:
Dr. Jim Aguanno, Ph.D.
Senior Clinical Consultant, Siemens Healthineers
Dr. Jim Aguanno has over 40 years of experience in laboratory medicine. He received a Bachelor of Science in Chemistry and a Ph.D. in Biochemistry from Memphis State University. Following his Ph.D., he did two post-doctoral fellowships one at the University of Pittsburgh School of Medicine in Biochemistry and a second fellowship in Laboratory Medicine at Washington University School of Medicine and Barnes Hospital in St. Louis, Missouri. Dr. Aguanno was Director of the Core Laboratory at Baylor University Medical Center in Dallas, Texas for 24 years. Dr. Aguanno joined Siemens Healthcare Diagnostics in January of 2004 and is currently Senior Clinical Consultant in the Clinical and Scientific Affairs group focusing on cardiovascular disease, infectious diseases and general aspects of laboratory medicine.
